Warby Parker Inc.
General ticker "WRBY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $2.7B (TTM average)
Warby Parker Inc. follows the US Stock Market performance with the rate: 47.5%.
Estimated limits based on current volatility of 3.3%: low 27.99$, high 29.92$
Factors to consider:
- Total employees count: 3780 (+8.3%) as of 2024
- Top business risk factors: Growth challenges, Reputation and brand risks, E commerce risks, Corporate culture maintenance, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.99$, 31.61$]
- 2025-12-31 to 2026-12-31 estimated range: [19.02$, 31.67$]
Financial Metrics affecting the WRBY estimates:
- Positive: with PPE of 123.2 at the end of fiscal year the price was neutral
- Positive: -5.02 < Operating profit margin, % of -3.76
- Positive: -3.57 < Return on assets ratio (scaled to [-100,100]) of -2.93
- Positive: 0.04 < Operating cash flow per share per price, % of 3.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 42.53 < Shareholder equity ratio, % of 50.27 <= 64.17
- Negative: Industry operating cash flow per share per price (median), % of 1.00 <= 5.42
- Negative: Industry operating profit margin (median), % of -6.69 <= 2.95
Short-term WRBY quotes
Long-term WRBY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $598.11MM | $669.76MM | $771.32MM |
| Operating Expenses | $709.32MM | $741.76MM | $801.43MM |
| Operating Income | $-111.20MM | $-72.00MM | $-30.11MM |
| Non-Operating Income | $1.31MM | $9.23MM | $10.60MM |
| Income(Loss) | $-109.90MM | $-62.76MM | $-19.52MM |
| Taxes | $0.50MM | $0.43MM | $0.88MM |
| Profit(Loss)* | $-110.39MM | $-63.20MM | $-20.39MM |
| Stockholders Equity | $286.65MM | $301.79MM | $340.07MM |
| Inventory | $68.85MM | $62.23MM | $52.34MM |
| Assets | $568.71MM | $580.31MM | $676.49MM |
| Operating Cash Flow | $10.37MM | $60.99MM | $98.74MM |
| Capital expenditure | $60.18MM | $53.67MM | $64.03MM |
| Investing Cash Flow | $-60.18MM | $-54.67MM | $-66.03MM |
| Financing Cash Flow | $3.29MM | $2.87MM | $4.96MM |
| Earnings Per Share** | $-0.96 | $-0.54 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.